ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hiromi Wada
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, F.
Right arrow Articles by Ito, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, F.
Right arrow Articles by Ito, H.

Ann Thorac Surg 2000;70:1832-1838
© 2000 The Society of Thoracic Surgeons

Original article: general thoracic

Biological features and preoperative evaluation of mediastinal nodal status in non–small cell lung cancer

Fumihiro Tanaka, MDa,b, Kazuhiro Yanagihara, MDa,b, Yosuke Otake, MDa,b, Mio Li, MDa,b, Ryo Miyahara, MDa,b, Hiromi Wada, MDa,b, Harumi Ito, MDa,b

a Department of Thoracic Surgery, Kyoto University, Kyoto, Japan
b Department of Radiology, Fukui Medical University, Fukui, Japan

Address reprint requests to Dr Wada, Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, Shogoin-kawahara-cho 54, Sakyo-ku, Kyoto, 606-8507, Japan
e-mail: wadah{at}kuhp.kyoto-u.ac.jp

Presented at the Poster Session of the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.

Background. To examine whether biological features of primary tumor can help preoperative evaluation of mediastinal nodal status in non-small cell lung cancer.

Methods. A total of 450 patients who underwent tumor resection and mediastinal dissection were reviewed. p53 status and proliferative fraction (PI) were evaluated immunohistochemically.

Results. The accuracy of preoperative evaluation of mediastinal nodal status with computed tomography (CT) was 72.2%; mediastinal nodal metastases had not been revealed until operation in 59 patients (13.1%) (false-negative), and no metastasis was revealed in 66 patients (14.7%) although mediastinal nodal enlargement had been demonstrated by CT (false-positive). The number of false-negative patients was significantly larger when p53 aberrant expression was positive or when PI was higher. Combined with p53 status and PI, there were 27 false-negatives (24.1%) among patients with aberrant p53 expression and higher PI, whereas only two false-negatives (1.5%) among those with negative p53 expression and lower PI.

Conclusions. Mediastinoscopy may be recommended for tumor showing aberrant p53 expression and higher PI, even when CT demonstrates no mediastinal nodal enlargement.




This article has been cited by other articles:


Home page
 Asian Cardiovasc. Thorac. Ann.Home page
C. Gebitekin, A. S Bayram, B. Tunca, and S. A Balaban
Clinical Significance of p53 Gene Mutation in T1-2N0 Non-Small Cell Lung Cancer
Asian Cardiovasc Thorac Ann, February 1, 2007; 15(1): 35 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. Takenaka, S. Ishikawa, K. Yanagihara, R. Miyahara, S. Hasegawa, Y. Otake, Y. Morioka, C. Takahashi, M. Noda, H. Ito, et al.
Prognostic Significance of Reversion-Inducing Cysteine-Rich Protein With Kazal Motifs Expression in Resected Pathologic Stage IIIA N2 Non-Small-Cell Lung Cancer
Ann. Surg. Oncol., October 1, 2005; 12(10): 817 - 824.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. K. LeBlanc, B. M. Devereaux, T. F. Imperiale, K. Kesler, J. M. DeWitt, O. Cummings, D. Ciaccia, S. Sherman, P. Mathur, D. Conces, et al.
Endoscopic Ultrasound in Non-Small Cell Lung Cancer and Negative Mediastinum on Computed Tomography
Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 177 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Tanaka, K. Takenaka, H. Oyanagi, T. Fujinaga, Y. Otake, K. Yanagihara, H. Ito, and H. Wada
Skip mediastinal nodal metastases in non-small cell lung cancer
Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1114 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
F. Tanaka, K. Yanagihara, Y. Otake, Y. Kawano, R. Miyahara, K. Takenaka, H. Katakura, S. Ishikawa, H. Ito, and H. Wada
Prognostic Factors in Resected Pathologic (p-) Stage IIIA-N2, Non-Small-Cell Lung Cancer
Ann. Surg. Oncol., June 1, 2004; 11(6): 612 - 618.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. Shoji, F. Tanaka, T. Takata, K. Yanagihara, Y. Otake, N. Hanaoka, R. Miyahara, T. Nakagawa, Y. Kawano, S. Ishikawa, et al.
Clinical Significance of p21 Expression in Non-Small-Cell Lung Cancer
J. Clin. Oncol., September 15, 2002; 20(18): 3865 - 3871.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Tanaka, K. Yanagihara, Y. Otake, T. Yamada, T. Shoji, R. Miyahara, K. Inui, and H. Wada
Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)
Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 555 - 561.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.